Condition
Cervical Dilation
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed4
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05038891CompletedPrimary
Self-Obtained Ultrasound Scans for Measurement of Cervical Dilation and Effacement in Labor
NCT04529837CompletedPrimary
Ultrasound Assessment of DILAPAN-S
NCT03440723Not ApplicableCompletedPrimary
DilaCheck Cervical Dilation Measurement Trial
NCT04437576Unknown
Pregnancy and Latent Labor Biomarkers and Symptoms to Predict Cervical Dilation at Hospital Admission.
NCT02606643Not ApplicableCompletedPrimary
Balloon Catheter for Cervical Ripening
Showing all 5 trials